Scarica l'app Stockscreener
8.89
6.81%
-0.66
Dopo l'orario di chiusura:
8.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.55
Aprire:
$9.44
Volume 24 ore:
44,554
Relative Volume:
0.72
Capitalizzazione di mercato:
$124.80M
Reddito:
$49.98M
Utile/perdita netta:
$-9.64M
Rapporto P/E:
-12.52
EPS:
-0.71
Flusso di cassa netto:
$-4.86M
1 W Prestazione:
-11.09%
1M Prestazione:
-19.53%
6M Prestazione:
+76.24%
1 anno Prestazione:
+61.82%
Intervallo 1D:
$8.64
$9.45
Intervallo di 1 settimana:
$8.601
$10.18
Portata 52W:
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Nome
Champions Oncology Inc
Settore
Industria
Telefono
410-369-0365
Indirizzo
855 N. WOLFE STREET, BALTIMORE, NJ
Confronta CSBR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
8.89 | 124.80M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 130.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 75.53B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.72B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.51 | 26.76B | 3.32B | -860.46M | -1.04B | -8.32 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-12 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-11-18 | Iniziato | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Borsa (CSBR) Ultime notizie
Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024) - Yahoo Finance
Champions Oncology target raised to $12 at Craig-Hallum By Investing.com - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript - MSN
Champions Oncology Achieves Record Revenue and Profit - TipRanks
Champions Oncology earnings beat by $0.37, revenue topped estimates - Investing.com Canada
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations By Investing.com - Investing.com UK
CHAMPIONS ONCOLOGY Earnings Results: $CSBR Reports Quarterly Earnings - Nasdaq
Champions Oncology stock surges as earnings beat expectations - Investing.com India
Champions Oncology Reports Record Quarterly Revenue and Net Income - TradingView
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million - ACCESS Newswire
Stock Index Futures Gain After Yesterday’s Selloff, U.S. JOLTs Report in Focus - TradingView
Earnings Scheduled For March 11, 2025 - Benzinga
CHAMPIONS ONCOLOGY Earnings Preview: Recent $CSBR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Champions Oncology Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 - ACCESS Newswire
When Will Champions Oncology Report Q3 Results? Key Date for Oncology Research Leader - StockTitan
(CSBR) Technical Pivots with Risk Controls - Stock Traders Daily
Targeted Oncology Adds The Florida Society of Clinical Oncology to Its Strategic Alliance Partnership Program - Florida Trend
CSBR stock hits 52-week high at $10.91 amid robust growth - MSN
We're Interested To See How Champions Oncology (NASDAQ:CSBR) Uses Its Cash Hoard To Grow - Yahoo Finance
Champions Oncology Reports Quarterly Revenue of $6.7 Million - ACCESS Newswire
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 - ACCESS Newswire
ZERO Advocacy Summit Ignites National Movement for Prostate Cancer Reform, Rallying Patients, Survivors, and Policymakers on Capitol Hill - Yahoo Finance
Champions Oncology Reports Record Quarterly Revenue of $9.5 Million - ACCESS Newswire
Champions Oncology, Inc. to Host Earnings Call - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $7.6 Million - ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million - ACCESS Newswire
Champions Oncology (NASDAQ:CSBR) pulls back 16% this week, but still delivers shareholders notable 57% return over 1 year - Simply Wall St
CSBRChampions Oncolo Latest Stock News & Market Updates - StockTitan
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 - ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $10.8 Million - ACCESS Newswire
Prospect High students champions in fight against blood cancer - Daily Herald
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 - ACCESS Newswire
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting - ACCESS Newswire
Revolutionary Cancer Research Alert: Champions Oncology Unveils 17 Game-Changing Studies at AACR 2025 - StockTitan
Flow Cytometry Market Size to Worth USD 12.11 Billion by 2034 - GlobeNewswire
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024 - ACCESS Newswire
(CSBR) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $13.1 Million - ACCESS Newswire
Champions Oncology to Announce Fourth Quarter Financial Results on Monday, July 15, 2019 - ACCESS Newswire
Pre-market Movers: PALI, KROS, AVGR, TRVI... - RTTNews
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024 - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $12.9 Million - ACCESS Newswire
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - Benzinga
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2020 - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million - ACCESS Newswire
Champions Oncology Announces a Partnership with Cyclica to Develop Small Molecule Therapeutics - ACCESS Newswire
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 - ACCESS Newswire
Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification - ACCESS Newswire
Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations - ACCESS Newswire
Champions Oncology Inc Azioni (CSBR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):